News
Never mistake a woman’s meekness for weakness,” Serena Joy says in The Handmaid’s Tale. Gilead is a scary place. There is ...
An advocacy group is suing the Trump administration for failing to disclose details of a settlement with Gilead over patent ...
Washington has long failed to come up with a solution for rising drug prices that addresses the concerns of drugmakers, ...
3d
Barchart on MSNAre Wall Street Analysts Bullish on Gilead Sciences Stock?Gilead Sciences, Inc. (GILD), headquartered in Foster City, California, is a biopharmaceutical company that discovers, ...
Shares of Gilead Sciences Inc. GILD slid 2.15% to $112.29 Thursday, on what proved to be an all-around rough trading session ...
4d
Zacks Investment Research on MSNIs Most-Watched Stock Gilead Sciences, Inc. (GILD) Worth Betting on Now?Gilead Sciences (GILD) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...
Biopharmaceuticals stock Gilead Sciences ( GILD 3.08%) jumped 2.5% through 12:30 p.m. ET Friday after Needham & Co. upgraded ...
Gilead Sciences, Inc. has announced that it has received new approval from the U.S. Food and Drug Administration (FDA) for a ...
Similarly, Gilead has provided nearly $35.8 million in total philanthropic support for Black women-led and/or Black ...
Gilead (GILD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results